| Ticker Symbol: | KNDL |
|---|---|
| Exchange: | NASD |
| Contact Info: | 441 Vine Street Cincinnati OH 45202 513 381-5550 |
| CEO/President: | Candace Kendle |
| Industry: | Medical - Outpatient & Hm Care / Standard Industry Code: 8731 |
| Description: | Kendle International Inc. is a contract research organization that provides a broad range of Phase I through IV clinical research and drug development services to the pharmaceutical and biotechnology industries. They augment the research and development activities of pharmaceutical and biotechnology companies by offering high quality, value added clinical research services and proprietary information technology designed to reduce drug development time and expense. |
| Shares Outstanding: | 14,720 (000) | Market Value: | 284,650 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 90.59% | Number of Inst.Shareholders: | 11.54% |
| Last Quarter Sales: | 181.08 ($Mil.) | Last Quarter Net Income: | 10.97 ($Mil.) |
| Last Quarter EPS: | 0.73 | P/E Ratio: | 9 |
| Most Recent Earnings: | 0.73 on 11/04/08 | Earnings Per Share: | 2.06 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| CHARLES RIVER L | -69.80 | 23.76 | |
| QUEST DIAGNOSTC | -13.20 | 46.82 | |
| HEALTHSOUTH CP | -54.00 | 11.19 | |
| DAVITA INC | -9.30 | 52.18 | |
| ICON PLC | -48.20 | 18.86 |
